SOD1 and endothelial dysfunction: MN40403, another highly specific nonpeptide SOD mimetic, was able to reverse endothelial dysfunction ex vivo by targeting NADPH oxidase-mediated superoxide production at aorta level of apolipoprotein E-deficient mice [58, 338].